In the service of Health

 
2015 is the 20th anniversary of MédiS laboratories.

2015 is the 20th anniversary of MédiS laboratories.

"It‘s been 20 years ago when MédiS was just an ambition with vague outline, A lined intuition of a profound conviction of success of the dream of my life..." Lassaad BOUJBEL | Founder and Pharmacist MédiS CEO

Lire la suite

Quality Control Laboratory

Quality Control Laboratory

The quality control department, within MédiS Laboratories, is one of the complex systems of quality evaluation in its widest sense, ensuring diverse activities of control and expertise…

Lire la suite

News

02.03.2015

Medis launches cis-atracurium : CISATREX®

Enhanced by the great and positive experience in the field of anesthesiology and medical reanimation, MédiS proves once again that it is  the main actor  in this area by launching his CISATREX® 10mg / 5ml, first-to-market the generic of Cis-atracurium in Tunisia.

CISATREX® (Cis-atracurium) is an Intermediate acting muscle relaxant which allows accomplishing anestesiologic and surgical acts in calmness  and serenity even though field is  difficult.

In anesthesiology, CISATREX® facilitates endotracheal intubation and immobility and in Intensive care unit the CISATREX® facilitates ventilation.

The first main advantage for CISATREX® is that it lacks the possibility of histamine release.

On the other hand, CISATREX® is the ideal choice for a patient with renal or hepatic insufficiency requiring muscle relaxation (Hoffman degradation independant  of kidney and liver).

In the ICU & especially during the Acute Respiratory Distress Syndrome, CISATREX® improves oxygenation and reduces inflammatory response which improves the overall prognosis.

CISATREX® represents the know how of MédiS associated with an  important health economic.